{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:28:53Z","timestamp":1760236133075,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2G12MD007595"],"award-info":[{"award-number":["2G12MD007595"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>To search for novel androgen receptor (AR) modulators for the potential treatment of castration-resistant prostate cancer (CRPC), naturally occurring silibinin was sought after as a lead compound because it possesses a moderate potency towards AR-positive prostate cancer cells and its chemical scaffold is dissimilar to all currently marketed AR antagonists. On the basis of the structure\u2013activity relationships that we have explored, this study aims to incorporate carbamoyl groups to the alcoholic hydroxyl groups of silibinin to improve its capability in selectively suppressing AR-positive prostate cancer cell proliferation together with water solubility. To this end, a feasible approach was developed to regioselectively introduce a carbamoyl group to the secondary alcoholic hydroxyl group at C-3 without causing the undesired oxidation at C2\u2013C3, providing an avenue for achieving 3-O-carbamoyl-5,7,20-O-trimethylsilybins. The application of the synthetic method can be extended to the synthesis of 3-O-carbamoyl-3\u2032,4\u2032,5,7-O-tetramethyltaxifolins. The antiproliferative potency of 5,7,20-O-trimethylsilybin and its nine 3-carbamoyl derivatives were assessed in an AR-positive LNCaP prostate cancer cell line and two AR-null prostate cancer cell lines (PC-3 and DU145). Our preliminary bioassay data imply that 5,7,20-O-trimethylsilybin and four 3-O-carbamoyl-5,7,20-O-trimethylsilybins emerge as very promising lead compounds due to the fact that they can selectively suppress AR-positive LNCaP cell proliferation. The IC50 values of these five 5,7,20-O-trimethylsilybins against the LNCaP cells fall into the range of 0.11\u20130.83 \u00b5M, which exhibit up to 660 times greater in vitro antiproliferative potency than silibinin. Our findings suggest that carbamoylated 5,7,20-O-trimethylsilybins could serve as a natural product-based scaffold for new antiandrogens for lethal castration-resistant prostate cancer.<\/jats:p>","DOI":"10.3390\/molecules26216421","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T22:07:11Z","timestamp":1635113231000},"page":"6421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["3-O-Carbamoyl-5,7,20-O-trimethylsilybins: Synthesis and Preliminary Antiproliferative Evaluation"],"prefix":"10.3390","volume":"26","author":[{"given":"Sitong","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, California State University, Fresno, CA 93740, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, California State University, Fresno, CA 93740, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Chemistry and RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangdi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Chemistry and RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-1824","authenticated-orcid":false,"given":"Qiao-Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, California State University, Fresno, CA 93740, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/med.21548","article-title":"Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain","volume":"39","author":"Elshan","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rajaram, P., Rivera, A., Muthima, K., Olveda, N., Muchalski, H., and Chen, Q.-H. (2020). Second-generation androgen receptor antagonists as hormonal therapeutics for three forms of prostate cancer. Molecules, 25.","DOI":"10.3390\/molecules25102448"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"Mateo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1158\/1078-0432.CCR-20-0394","article-title":"Non-BRCA DNA damage repair gene alteration and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: Analysis from the phase II TRITON2 study","volume":"26","author":"Abida","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.jmedchem.8b01631","article-title":"Discovery of ARD-69 as a highly potent proteolysis targeting chimera (PROTAC) degrader of androgen receptor (AR) for the treatment of prostate cancer","volume":"62","author":"Han","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_7","first-page":"3500","article-title":"Recent advances in the management of metastatic prostate cancer","volume":"38","author":"Sayegh","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s40425-019-0741-7","article-title":"CAR-T cell therapy: A potential new strategy against prostate cancer","volume":"7","author":"Schepisi","year":"2019","journal-title":"Immunother. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/S0040-4039(00)89610-0","article-title":"The structure of silybin (Silybum substance E6), the first flavonolignan","volume":"9","author":"Pelter","year":"1968","journal-title":"Tetrahedron Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/1534735407301825","article-title":"Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies","volume":"6","author":"Kroll","year":"2007","journal-title":"Integr. Cancer Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1158\/0008-5472.CAN-04-4662","article-title":"Milk thistle and prostate cancer: Differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells","volume":"65","author":"Nakanishi","year":"2005","journal-title":"Cancer Res."},{"key":"ref_12","first-page":"3063","article-title":"Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels","volume":"62","author":"Singh","year":"2002","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1158\/0008-5472.CAN-07-2222","article-title":"Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model","volume":"67","author":"Raina","year":"2007","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2174\/0929867323666160823151833","article-title":"The potential of flavonolignans in prostate cancer management","volume":"23","author":"Vue","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/01.ju.0000121329.37206.1b","article-title":"Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells","volume":"171","author":"Thelen","year":"2004","journal-title":"J. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/carcin\/22.9.1399","article-title":"Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP","volume":"22","author":"Zhu","year":"2001","journal-title":"Carcinogenesis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1073\/pnas.96.13.7490","article-title":"Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention","volume":"96","author":"Zi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/mc.20670","article-title":"Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-\u03baB, and androgen receptor signaling","volume":"49","author":"Deep","year":"2010","journal-title":"Mol. Carcinog."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10637-006-9019-2","article-title":"A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients","volume":"25","author":"Flaig","year":"2007","journal-title":"Investig. New Drugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmech.2015.12.041","article-title":"Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations","volume":"109","author":"Vue","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Vue, B., Zhang, S., Vignau, A., Chen, G., Zhang, X., Diaz, W., Zhang, Q., Zheng, S., Wang, G., and Chen, Q.-H. (2018). O-aminoalkyl-O-trimethyl-2,3-dehydrosilybins: Synthesis and in vitro effects towards prostate cancer cells. Molecules, 23.","DOI":"10.20944\/preprints201810.0768.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/j.bmcl.2016.05.069","article-title":"3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells","volume":"26","author":"Zhang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bmc.2012.11.035","article-title":"Enhanced bioactivity of silybin B methylation products","volume":"21","author":"Graf","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Agarwal, C., Wadhwa, R., Deep, G., Biedermann, D., Ga\u017e\u00e1k, R., K\u0159en, V., and Agarwal, R. (2013). Anti-cancer efficacy of silybin derivatives\u2014A structure-activity relationship. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060074"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bioorg.2018.01.026","article-title":"Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations","volume":"77","author":"Romanucci","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1021\/jm900735p","article-title":"Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives","volume":"52","author":"Yang","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_27","first-page":"1934578X20922326","article-title":"23-O-Substituted-2,3-dehydrosilybins selectively suppress androgen receptor-positive LNCaP prostate cancer cell proliferation","volume":"15","author":"Jiang","year":"2020","journal-title":"Nat. Prod. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bmc.2008.12.002","article-title":"Design, synthesis and biological evaluation of novel stilbene-based antitumor agents","volume":"17","author":"Simoni","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/jm701456r","article-title":"Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: Synthesis, pharmacodynamics, and pharmacokinetics","volume":"51","author":"Chassaing","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1039\/C3NP70122K","article-title":"Chemistry of silybin","volume":"31","author":"Biedermann","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1021\/jo00303a016","article-title":"Substrate leaving group control of the enantioselectivity in the palladium-catalyzed asymmetric allylic substitution of 4-alkyl-1-vinylcyclohexyl derivatives","volume":"55","author":"Fiaud","year":"1990","journal-title":"J. Org. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tetlet.2012.11.049","article-title":"Base-catalyzed oxidation of silybin and isosilybin into 2,3-dehydro derivatives","volume":"54","author":"Gazak","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/jo00326a044","article-title":"Formation of olefins in the pyrolysis of N,N-disubstituted carbamates","volume":"46","author":"Atkinson","year":"1981","journal-title":"J. Org. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1016\/j.bmc.2004.07.064","article-title":"Oxidized derivatives of silybin and their antiradical and antioxidant activity","volume":"12","author":"Gazak","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1039\/C7OB00654C","article-title":"Transition-metal-free synthesis of 1,1-diboronate esters with a fully substituted benzylic center via diborylation of lithiated carbamates","volume":"15","author":"Zhao","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"12285","DOI":"10.1002\/anie.201606641","article-title":"Stereospecific synthesis of alkenes by eliminative cross-coupling of enantioenriched sp(3) -hybridized carbenoids","volume":"55","author":"Wu","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/jo101886s","article-title":"Chemoselective C-4 aerobic oxidation of catechin derivatives catalyzed by the trametes villosa laccase\/1-hydroxybenzotriazole system: Synthetic and mechanistic aspects","volume":"76","author":"Bernini","year":"2011","journal-title":"J. Org. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/0031-9422(80)85075-8","article-title":"Leucocyanidin: Synthesis and properties of (2R,3S,4R)-(+)-3,4,5,7,3\u2019,4\u2019-hexahydroxyflavan","volume":"21","author":"Porter","year":"1980","journal-title":"Phytochemistry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1021\/ja3001584","article-title":"Exciton chirality method in vibrational circular dichroism","volume":"134","author":"Taniguchi","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1021\/np034005w","article-title":"Methylation of dihydroquercetin acetates: Synthesis of 5-O-methyldihydroquercetin","volume":"66","author":"Kiehlmann","year":"2003","journal-title":"J. Nat. Prod."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/21\/6421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:22:25Z","timestamp":1760167345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/21\/6421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,24]]},"references-count":40,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["molecules26216421"],"URL":"https:\/\/doi.org\/10.3390\/molecules26216421","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2021,10,24]]}}}